Preoperative chemoradiation for rectal cancer

results of multimodality management and analysis of prognostic factors

Anand T. Shivnani, William Small, Steven J. Stryker, Krystyna D. Kiel, Sherry Lim, Amy L Halverson, Mark S. Talamonti*

*Corresponding author for this work

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Background: Our goals were to examine the impact of neoadjuvant chemoradiation for rectal cancer on surgical outcomes and to determine prognostic factors predicting improved survival. Methods: Retrospective cohort of 56 male and 44 female patients. Results: After preoperative chemoradiation, 73% of patients had sphincter-preserving surgery. The 5-year disease-free (DFS) and overall survival rates were 77% and 81%, respectively. Twenty-five percent of patients showed a complete pathologic response. T-level downstaging and pathologic T stage did not correlate with recurrence or survival rates. Pathologic nodal stage was associated with a significant difference in recurrence rates (N0 19%, N1 20%, and N2 75%, P = .038) and DFS (N0/N1 vs. N2, 79% vs. 25%, P = .002). Conclusion: Neoadjuvant chemoradiation resulted in a high rate of sphincter preservation. Complete pathologic responses after surgery were frequent and although pathologic T stage after surgery did not affect recurrence rates, pathologic nodal response was associated with improved recurrence and survival rates.

Original languageEnglish (US)
Pages (from-to)389-394
Number of pages6
JournalAmerican Journal of Surgery
Volume193
Issue number3
DOIs
StatePublished - Mar 1 2007

Fingerprint

Rectal Neoplasms
Recurrence
Survival Rate
Survival

Keywords

  • Neoadjuvant chemoradiation
  • Rectal cancer
  • Rectal surgery

ASJC Scopus subject areas

  • Surgery

Cite this

Shivnani, Anand T. ; Small, William ; Stryker, Steven J. ; Kiel, Krystyna D. ; Lim, Sherry ; Halverson, Amy L ; Talamonti, Mark S. / Preoperative chemoradiation for rectal cancer : results of multimodality management and analysis of prognostic factors. In: American Journal of Surgery. 2007 ; Vol. 193, No. 3. pp. 389-394.
@article{0233e7bee879411483c2503d2bcac74b,
title = "Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors",
abstract = "Background: Our goals were to examine the impact of neoadjuvant chemoradiation for rectal cancer on surgical outcomes and to determine prognostic factors predicting improved survival. Methods: Retrospective cohort of 56 male and 44 female patients. Results: After preoperative chemoradiation, 73{\%} of patients had sphincter-preserving surgery. The 5-year disease-free (DFS) and overall survival rates were 77{\%} and 81{\%}, respectively. Twenty-five percent of patients showed a complete pathologic response. T-level downstaging and pathologic T stage did not correlate with recurrence or survival rates. Pathologic nodal stage was associated with a significant difference in recurrence rates (N0 19{\%}, N1 20{\%}, and N2 75{\%}, P = .038) and DFS (N0/N1 vs. N2, 79{\%} vs. 25{\%}, P = .002). Conclusion: Neoadjuvant chemoradiation resulted in a high rate of sphincter preservation. Complete pathologic responses after surgery were frequent and although pathologic T stage after surgery did not affect recurrence rates, pathologic nodal response was associated with improved recurrence and survival rates.",
keywords = "Neoadjuvant chemoradiation, Rectal cancer, Rectal surgery",
author = "Shivnani, {Anand T.} and William Small and Stryker, {Steven J.} and Kiel, {Krystyna D.} and Sherry Lim and Halverson, {Amy L} and Talamonti, {Mark S.}",
year = "2007",
month = "3",
day = "1",
doi = "10.1016/j.amjsurg.2006.09.030",
language = "English (US)",
volume = "193",
pages = "389--394",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "3",

}

Preoperative chemoradiation for rectal cancer : results of multimodality management and analysis of prognostic factors. / Shivnani, Anand T.; Small, William; Stryker, Steven J.; Kiel, Krystyna D.; Lim, Sherry; Halverson, Amy L; Talamonti, Mark S.

In: American Journal of Surgery, Vol. 193, No. 3, 01.03.2007, p. 389-394.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Preoperative chemoradiation for rectal cancer

T2 - results of multimodality management and analysis of prognostic factors

AU - Shivnani, Anand T.

AU - Small, William

AU - Stryker, Steven J.

AU - Kiel, Krystyna D.

AU - Lim, Sherry

AU - Halverson, Amy L

AU - Talamonti, Mark S.

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Background: Our goals were to examine the impact of neoadjuvant chemoradiation for rectal cancer on surgical outcomes and to determine prognostic factors predicting improved survival. Methods: Retrospective cohort of 56 male and 44 female patients. Results: After preoperative chemoradiation, 73% of patients had sphincter-preserving surgery. The 5-year disease-free (DFS) and overall survival rates were 77% and 81%, respectively. Twenty-five percent of patients showed a complete pathologic response. T-level downstaging and pathologic T stage did not correlate with recurrence or survival rates. Pathologic nodal stage was associated with a significant difference in recurrence rates (N0 19%, N1 20%, and N2 75%, P = .038) and DFS (N0/N1 vs. N2, 79% vs. 25%, P = .002). Conclusion: Neoadjuvant chemoradiation resulted in a high rate of sphincter preservation. Complete pathologic responses after surgery were frequent and although pathologic T stage after surgery did not affect recurrence rates, pathologic nodal response was associated with improved recurrence and survival rates.

AB - Background: Our goals were to examine the impact of neoadjuvant chemoradiation for rectal cancer on surgical outcomes and to determine prognostic factors predicting improved survival. Methods: Retrospective cohort of 56 male and 44 female patients. Results: After preoperative chemoradiation, 73% of patients had sphincter-preserving surgery. The 5-year disease-free (DFS) and overall survival rates were 77% and 81%, respectively. Twenty-five percent of patients showed a complete pathologic response. T-level downstaging and pathologic T stage did not correlate with recurrence or survival rates. Pathologic nodal stage was associated with a significant difference in recurrence rates (N0 19%, N1 20%, and N2 75%, P = .038) and DFS (N0/N1 vs. N2, 79% vs. 25%, P = .002). Conclusion: Neoadjuvant chemoradiation resulted in a high rate of sphincter preservation. Complete pathologic responses after surgery were frequent and although pathologic T stage after surgery did not affect recurrence rates, pathologic nodal response was associated with improved recurrence and survival rates.

KW - Neoadjuvant chemoradiation

KW - Rectal cancer

KW - Rectal surgery

UR - http://www.scopus.com/inward/record.url?scp=33847200792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847200792&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2006.09.030

DO - 10.1016/j.amjsurg.2006.09.030

M3 - Article

VL - 193

SP - 389

EP - 394

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 3

ER -